SCHEMBL6981060

SCHEMBL6981060

CCCNc1cc[c]nn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
HCAR3 P49019 1/20 0.37
ALDH1A1 P00352 2/20 0.34
BLM P54132 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ABCB1 P08183 1/20 0.33
ABCC1 P33527 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TNIK Q9UKE5 1/20 0.33
PIM1 P11309 1/20 0.33
LMNA P02545 1/20 0.33
IDO1 P14902 1/20 0.33
SOAT1 P35610 2/20 0.32
CCNC P24863 1/20 0.32
HTT P42858 1/20 0.32
CDK8 P49336 1/20 0.32
NR1I2 O75469 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1110459 0.80 CYP2C19 (0.47)
SCHEMBL14294339 0.72 HCAR3 (0.42) ESR1ESR2HCAR3ALDH1A1HPGD
SCHEMBL991740 0.69 HCAR3 (0.44) ESR1ESR2HCAR3ALDH1A1BLM
SCHEMBL5940546 0.67 GOT1 (0.50) ESR1ESR2HCAR3ALDH1A1BLM
SCHEMBL27401621 0.67 MAPT (0.50) HCAR3ALDH1A1HPGDSMN1; SMN2PIM1
SCHEMBL4757637 0.67 L3MBTL1 (0.48) ALDH1A1L3MBTL1HPGDSMN1; SMN2LMNA
SCHEMBL4889623 0.67 HCAR3 (0.41) ESR1ESR2HCAR3ALDH1A1HPGD
SCHEMBL14734750 0.66 MEN1 (0.32) SMN1; SMN2HTT
SCHEMBL1778120 0.65
SCHEMBL4247629 0.65 RRM2 (0.35) HCAR3ALDH1A1HPGDSMN1; SMN2TNIK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326831-A1 SUBSTITUTED FUSED PYRROLEIMINES AND PYRAZOLEIMINES NEUROGEN CORPORATION (US) 2003-07-16 EP disclosed
WO-2002020480-A1 SUBSTITUTED FUSED PYRROLEIMINES AND PYRAZOLEIMINES NEUROGEN CORPORATION (US) 2002-03-14 WO disclosed